Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Codominant interference, antieffectors, and multitarget drugs

A Varshavsky1

  • 1Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA. avarsh@cco.caltech.edu

Proceedings of the National Academy of Sciences of the United States of America
|April 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent studies of the ubiquitin system and the N-end rule pathway.

Harvey lectures·2002
Same author

Construction and analysis of mouse strains lacking the ubiquitin ligase UBR1 (E3alpha) of the N-end rule pathway.

Molecular and cellular biology·2001
Same author

The 2000 Genetics Society of America Medal. Jack W. Szostak.

Genetics·2001
Same author

Degradation of a cohesin subunit by the N-end rule pathway is essential for chromosome stability.

Nature·2001
Same author

RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: a negative feedback circuit.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Felix Hoppe-Seyler Lecture 2000. The ubiquitin system and the N-end rule pathway.

Biological chemistry·2000
Same journal

Chemotactic self-organization captures the dynamics of mammalian hair follicle patterning.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Tomographic imaging of superconducting order using particle-hole interference.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Improving cell-free metabolism through direct integration of artificial respiratory chains.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles

This study introduces a novel approach to enhance drug selectivity using codominant interference and antieffector strategies for small molecule drugs. This combinatorial selectivity promises more effective and safer therapies by targeting specific cellular molecular profiles.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Drug selectivity remains a significant challenge in modern therapeutics, particularly for anticancer drugs, leading to severe side effects and limited efficacy.
  • Current multitarget drug designs are often limited to macromolecular reagents, facing issues with intracellular delivery and immunogenicity.

Purpose of the Study:

  • To propose a novel strategy for achieving combinatorial drug selectivity applicable to small molecules (
  • To introduce the concepts of codominant interference and antieffectors for precise therapeutic targeting.

Main Methods:

  • The study proposes a theoretical framework for designing small molecule drugs with combinatorial selectivity.
  • It introduces the concepts of 'codominant interference' and 'antieffectors' to achieve precise cellular targeting based on the presence or absence of specific molecular targets.

Related Experiment Videos

Main Results:

  • The proposed approach enables therapeutic agents to possess combinatorial selectivity, targeting cells with a specific combination of molecular targets while sparing others.
  • This method allows for Boolean logic-based drug action (AND, OR, etc.) for precise therapeutic outcomes.
  • The strategy is applicable to small drugs, overcoming limitations of macromolecular reagents.

Conclusions:

  • Codominant interference and antieffector concepts offer a viable solution to the problem of drug selectivity for small molecules.
  • This approach has the potential to significantly improve the efficacy and safety of drugs, especially in cancer therapy.
  • Further research into pharmacokinetics and in vivo applications of these multitarget drugs is warranted.